Raymond James Financial Services Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-35,079
Closed -$6.44M 3373
2021
Q2
$6.44M Buy
35,079
+3,820
+12% +$702K 0.01% 860
2021
Q1
$4.78M Sell
31,259
-8,861
-22% -$1.35M 0.01% 927
2020
Q4
$6.27M Sell
40,120
-10,372
-21% -$1.62M 0.02% 741
2020
Q3
$5.78M Buy
50,492
+18,439
+58% +$2.11M 0.02% 698
2020
Q2
$3.6M Sell
32,053
-2,466
-7% -$277K 0.01% 840
2020
Q1
$3.1M Buy
34,519
+10,320
+43% +$926K 0.01% 697
2019
Q4
$2.62M Buy
24,199
+1,568
+7% +$170K 0.01% 1040
2019
Q3
$2.22M Buy
22,631
+2,297
+11% +$225K 0.01% 1049
2019
Q2
$2.66M Buy
20,334
+279
+1% +$36.5K 0.01% 947
2019
Q1
$2.71M Sell
20,055
-2,243
-10% -$303K 0.01% 921
2018
Q4
$2.17M Buy
22,298
+548
+3% +$53.4K 0.01% 860
2018
Q3
$3.02M Sell
21,750
-5,726
-21% -$796K 0.01% 859
2018
Q2
$3.41M Buy
27,476
+1,464
+6% +$182K 0.02% 762
2018
Q1
$2.9M Sell
26,012
-1,423
-5% -$159K 0.02% 779
2017
Q4
$3.28M Sell
27,435
-3,109
-10% -$372K 0.02% 706
2017
Q3
$4.29M Sell
30,544
-4,238
-12% -$595K 0.03% 582
2017
Q2
$4.23M Buy
34,782
+2,871
+9% +$349K 0.03% 566
2017
Q1
$3.87M Sell
31,911
-20,522
-39% -$2.49M 0.03% 573
2016
Q4
$6.42M Sell
52,433
-99,772
-66% -$12.2M 0.05% 374
2016
Q3
$18.7M Sell
152,205
-478
-0.3% -$58.6K 0.17% 146
2016
Q2
$17.8M Buy
152,683
+4,775
+3% +$558K 0.17% 146
2016
Q1
$20.6M Buy
147,908
+30,907
+26% +$4.3M 0.24% 97
2015
Q4
$22.3M Buy
+117,001
New +$22.3M 0.26% 90